Clinical Trial Update: Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy [Phase 2]

View source ↗

Summary

A completed Phase 2 exploratory trial assessed the metabolic effects of adding ranolazine to ongoing non-insulin antidiabetic therapy in people with type 2 diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ranolazine (Ranexa) (Ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2013-09-23